Contact
searchSearch
HMP Global
Conference Coverage
Real-World Analysis of Persistence and Prescribing Patterns of TV-46000 for Schizophrenia Treatment
10/15/2024
This study on the prescribing patterns of TV-46000 for schizophrenia treatment in the US reveals high persistence rates and frequent use as a first-line treatment option among patients.
This study on the prescribing patterns of TV-46000 for schizophrenia treatment in the US reveals high persistence rates and frequent use as a first-line treatment option among patients.
This study on the prescribing...
10/15/2024
First Report Managed Care
Conference Coverage
Increasing Prescriptions, Decreasing Results: Studying GLP-1 Weight Loss Use Trends
10/15/2024
A surge in GLP-1 drug use for weight management in the US has led to decreasing rates of sustained use and meaningful weight loss, as highlighted in a recent study analyzing trends in medication persistence and outcomes.
A surge in GLP-1 drug use for weight management in the US has led to decreasing rates of sustained use and meaningful weight loss, as highlighted in a recent study analyzing trends in medication persistence and outcomes.
A surge in GLP-1 drug use for...
10/15/2024
First Report Managed Care
Interview
Key Pharmaceutical Pipeline Developments: Insights from Industry Experts
05/29/2024
Leslie Fish, RPh, Senior Vice President of Clinical Pharmacy, IPD Analytics, LLC
Jeffrey Casberg, MS, RPh, IPD, Vice President of Clinical Pharmacy, IPD Analytics, LLC
Learn about promising drugs currently in the pharmaceutical pipeline and the impact of FDA interventions from presenters at AMCP 2024.
Learn about promising drugs currently in the pharmaceutical pipeline and the impact of FDA interventions from presenters at AMCP 2024.
Learn about promising drugs...
05/29/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Meron Gartner
Interview
Leveraging Pharmacists to Resolve Social Determinants of Health Barriers and Improve Patient Outcomes
05/24/2024
Meron Gartner, PharmD, Senior Product Manager, Payer Products, Outcomes
Guest expert and AMCP 2024 presenter Meron Gartner, PharmD, elaborates on how pharmacists play a crucial role in addressing social determinants of health by engaging with patients, identifying barriers, and connecting them to resources for...
Guest expert and AMCP 2024 presenter Meron Gartner, PharmD, elaborates on how pharmacists play a crucial role in addressing social determinants of health by engaging with patients, identifying barriers, and connecting them to resources for...
Guest expert and AMCP 2024...
05/24/2024
First Report Managed Care
Sarah Emond
Interview
Improving Patient Engagement in Managed Care Pharmacy Through Collaboration
05/21/2024
Sarah Emond, MPP, President and Chief Executive Officer, ICER
Patient perspectives play a crucial role in shaping healthcare decisions, and AMCP 2024 session speaker Sarah Emond discusses the importance of patient engagement in drug value assessments within the managed care framework, providing examples...
Patient perspectives play a crucial role in shaping healthcare decisions, and AMCP 2024 session speaker Sarah Emond discusses the importance of patient engagement in drug value assessments within the managed care framework, providing examples...
Patient perspectives play a...
05/21/2024
First Report Managed Care
Joe Honcz
Interview
Exploring Future Possibilities of AI in Managed Care Pharmacy Practice
05/20/2024
Joseph Honcz, RPh, MBA
Guest expert and AMCP 2024 session presenter Joseph Honcz, RPh, MBA, explores the current role of AI in managed care, barriers to implementation, and strategies for collaborating with managed care leadership to advance the testing of AI...
Guest expert and AMCP 2024 session presenter Joseph Honcz, RPh, MBA, explores the current role of AI in managed care, barriers to implementation, and strategies for collaborating with managed care leadership to advance the testing of AI...
Guest expert and AMCP 2024...
05/20/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Conference Coverage
Specialty Pharmaceuticals Pipeline: Biologic and Biosimilar Approvals and Projected Developments
04/29/2024
Explore the latest trends and developments in the specialty pharmaceutical pipeline, including key legal matters, FDA issues, notable approvals, and potential biosimilar savings projected for the next decade as shared in a 2024 AMCP session.
Explore the latest trends and developments in the specialty pharmaceutical pipeline, including key legal matters, FDA issues, notable approvals, and potential biosimilar savings projected for the next decade as shared in a 2024 AMCP session.
Explore the latest trends and...
04/29/2024
First Report Managed Care
Conference Coverage
Pharmaceutical Industry Trend and Prediction Highlights from AMCP 2024
04/26/2024
A keynote session at AMCP 2024 outlined pharmaceutical industry trends and predictions for pharmacy benefits management (PBMs), including challenges and disruptors like the Inflation Reduction Act (IRA), changing consumer preferences, rising...
A keynote session at AMCP 2024 outlined pharmaceutical industry trends and predictions for pharmacy benefits management (PBMs), including challenges and disruptors like the Inflation Reduction Act (IRA), changing consumer preferences, rising...
A keynote session at AMCP 2024...
04/26/2024
First Report Managed Care
Conference Coverage
Strategies for Harnessing AI to Improve Managed Care
04/18/2024
During a panel discussion at AMCP 2024, Sean Jeffery, PharmD, BCGP, FASCP, AGSF, Jay Rajda, MD, MBA, Shawn Wang, Chief AI Officer at Elevance Health, and Joseph Honcz, RPh, MBA, detailed case studies to examine the current and future...
During a panel discussion at AMCP 2024, Sean Jeffery, PharmD, BCGP, FASCP, AGSF, Jay Rajda, MD, MBA, Shawn Wang, Chief AI Officer at Elevance Health, and Joseph Honcz, RPh, MBA, detailed case studies to examine the current and future...
During a panel discussion at...
04/18/2024
First Report Managed Care
Conference Coverage
A Global Perspective on the Development of Value-Based Care and Innovative Contracting
04/18/2024
Global trends in pharmaceutical pricing strategies and innovative contracting models, the increasing complexities of drug pricing, and the potential risks of an overinflated market bubble were discussed in a keynote session with Omar Ali,...
Global trends in pharmaceutical pricing strategies and innovative contracting models, the increasing complexities of drug pricing, and the potential risks of an overinflated market bubble were discussed in a keynote session with Omar Ali,...
Global trends in pharmaceutical...
04/18/2024
First Report Managed Care
Conference Coverage
PBM Legislation: Navigating Congressional Delays and Encouraging Progress
04/17/2024
Explore the world of federal pharmacy benefit manager (PBM) legislation and its potential impact on stakeholders in this in-depth analysis presented by Ross Margulies, JD, MPH, Partner and Co-Chair Healthcare and Life Sciences Coverage &...
Explore the world of federal pharmacy benefit manager (PBM) legislation and its potential impact on stakeholders in this in-depth analysis presented by Ross Margulies, JD, MPH, Partner and Co-Chair Healthcare and Life Sciences Coverage &...
Explore the world of federal...
04/17/2024
First Report Managed Care
Conference Coverage
Understanding the Mechanics of Medicare and Beneficiary Challenges
04/17/2024
Sean Chitwood, PharmD, MBA, Clinical Pharmacist, Medicare Stars & Clinical Quality, Government Programs at OptumRx, and Justin Bioc, PharmD, BCPS, BCGP, RPh, Head of Clinical Pharmacy at Devoted Health explored the complexities and nuances of...
Sean Chitwood, PharmD, MBA, Clinical Pharmacist, Medicare Stars & Clinical Quality, Government Programs at OptumRx, and Justin Bioc, PharmD, BCPS, BCGP, RPh, Head of Clinical Pharmacy at Devoted Health explored the complexities and nuances of...
Sean Chitwood, PharmD, MBA,...
04/17/2024
First Report Managed Care
Conference Coverage
Multi-Year Educational Initiative Aims to Expand Understanding of Atopic Dermatitis for Managed Care Professionals
04/11/2024
An educational initiative aiming to improve access to high-quality care for individuals with atopic dermatitis by expanding managed care professionals' understanding of this condition will be presented at AMCP 2024.
An educational initiative aiming to improve access to high-quality care for individuals with atopic dermatitis by expanding managed care professionals' understanding of this condition will be presented at AMCP 2024.
An educational initiative aiming...
04/11/2024
First Report Managed Care
Conference Coverage
Real-World Treatment Barriers for Patients With Chronic Idiopathic Constipation
04/11/2024
New research to be presented at AMCP 2024 sheds light on the challenges faced by patients with chronic idiopathic constipation in accessing and affording medication, highlighting the need for improved awareness and insurance coverage.
New research to be presented at AMCP 2024 sheds light on the challenges faced by patients with chronic idiopathic constipation in accessing and affording medication, highlighting the need for improved awareness and insurance coverage.
New research to be presented at...
04/11/2024
First Report Managed Care
Conference Coverage
The True Cost of Nonalcoholic Steatohepatitis Progression
04/11/2024
“These data show that the burden of care for NASH is substantial, and compared with those without progression, the annual costs per person with progression are at least 2-fold higher, with the gap increasing over time,” said researchers that...
“These data show that the burden of care for NASH is substantial, and compared with those without progression, the annual costs per person with progression are at least 2-fold higher, with the gap increasing over time,” said researchers that...
“These data show that the burden...
04/11/2024
First Report Managed Care
Conference Coverage
Uncovering the Impact of Health Inequalities on Clinical Outcomes in Patients With Lung Disease
04/10/2024
Research that will be presented at AMCP 2024 reveals significant disparities in resource use and clinical outcomes for US patients with pneumonia, COPD, and lung cancer, highlighting the impact of health inequalities on access to care and...
Research that will be presented at AMCP 2024 reveals significant disparities in resource use and clinical outcomes for US patients with pneumonia, COPD, and lung cancer, highlighting the impact of health inequalities on access to care and...
Research that will be presented...
04/10/2024
First Report Managed Care
Conference Coverage
Mepolizumab Treatment May Reduce Health Care Resource Utilization and OCS in Patients With CRSwNP
04/10/2024
Research that will be presented at AMCP 2024 suggests that mepolizumab treatment reduces health care costs and resource utilization in patients with chronic rhinosinusitis with nasal polyps.
Research that will be presented at AMCP 2024 suggests that mepolizumab treatment reduces health care costs and resource utilization in patients with chronic rhinosinusitis with nasal polyps.
Research that will be presented...
04/10/2024
First Report Managed Care
Conference Coverage
Exploring the Biosimilar Regulatory Landscape and Future Marketplace Potential
04/14/2023
Presenters at AMCP 2023 examined the regulatory landscape of biosimilars in the United States, explored key influencers for the adoption, and outlined the practical considerations for use.
Presenters at AMCP 2023 examined the regulatory landscape of biosimilars in the United States, explored key influencers for the adoption, and outlined the practical considerations for use.
Presenters at AMCP 2023 examined...
04/14/2023
First Report Managed Care
Headshot of Courtney Quinn, Navitus Health Solutions
Interview
Switching to Biosimilars Yields Significant Cost Savings For Patients Taking Insulin
04/13/2023
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1...
04/13/2023
First Report Managed Care
Conference Coverage
Real-World Strategies for Implementing Biosimilars
04/12/2023
Speakers at AMCP 2023 discussed the current landscape of biosimilars from a payer perspective as well as lessons learned from health system biosimilar adoption. 
Speakers at AMCP 2023 discussed the current landscape of biosimilars from a payer perspective as well as lessons learned from health system biosimilar adoption. 
Speakers at AMCP 2023 discussed...
04/12/2023
First Report Managed Care
Conference Coverage
Significant Financial Burden Associated With First-Line Urothelial Carcinoma Therapy
04/11/2023
More than half of Medicare members with urothelial carcinoma who received first-line systemic therapy experienced an adverse event, researchers found.
More than half of Medicare members with urothelial carcinoma who received first-line systemic therapy experienced an adverse event, researchers found.
More than half of Medicare...
04/11/2023
First Report Managed Care
Conference Coverage
Expanded NGS Biomarker Testing for Metastatic Colorectal Cancer Could Optimize Treatment With Manageable Costs
04/11/2023
Increasing next-generation sequencing testing for metastatic colorectal cancer may help optimize therapy selection without significantly increasing costs for US payers, researchers said.
Increasing next-generation sequencing testing for metastatic colorectal cancer may help optimize therapy selection without significantly increasing costs for US payers, researchers said.
Increasing next-generation...
04/11/2023
First Report Managed Care
Conference Coverage
Risdiplam May Reduce HCRU, Disease-Related Complications in Patients With SMA
03/29/2023
Researchers explored health care resource utilization and outcomes among patients with spinal muscular atrophy to discover the potential benefits of risdiplam therapy.
Researchers explored health care resource utilization and outcomes among patients with spinal muscular atrophy to discover the potential benefits of risdiplam therapy.
Researchers explored health care...
03/29/2023
First Report Managed Care
Conference Coverage
How Payers Can Address Barriers to Real-Time Benefit Check Adoption
03/24/2023
The session highlighted key obstacles to real-time benefit check adoption by providers and included advice for payers to overcome barriers.
The session highlighted key obstacles to real-time benefit check adoption by providers and included advice for payers to overcome barriers.
The session highlighted key...
03/24/2023
First Report Managed Care
Conference Coverage
Uncovering the Racial Expenditure Disparities in Patients With Colorectal Cancer
03/22/2023
Investigators at AMCP 2023 found the health care expenditure for African American and Hispanic patients with colorectal cancer was substantially lower than that of White patients.
Investigators at AMCP 2023 found the health care expenditure for African American and Hispanic patients with colorectal cancer was substantially lower than that of White patients.
Investigators at AMCP 2023 found...
03/22/2023
First Report Managed Care
Conference Coverage
Adopting a Patient-Focused Approach to Prior Authorization Criteria
03/22/2023
In a session at AMCP 2023, speakers shared the rationale driving current prior authorization practices, as well as how health plans might adopt a more patient-focused approach.
In a session at AMCP 2023, speakers shared the rationale driving current prior authorization practices, as well as how health plans might adopt a more patient-focused approach.
In a session at AMCP 2023,...
03/22/2023
First Report Managed Care
Conference Coverage
How the Accelerated Approval Pathway Impacts Rare Diseases, Cancer, and Alzheimer Disease
03/22/2023
Speakers at AMCP 2023 offered insight into the accelerated approval pathway's design and how drugs approved through this pathway impact managed care considerations for a variety of disease states.
Speakers at AMCP 2023 offered insight into the accelerated approval pathway's design and how drugs approved through this pathway impact managed care considerations for a variety of disease states.
Speakers at AMCP 2023 offered...
03/22/2023
First Report Managed Care
Conference Coverage
Federal Legislative Updates: PDTs, Performance-based Reimbursement, and More
03/22/2023
Presenters at AMCP 2023 reviewed recent prescription digital therapeutics legislation as well as new proposals anticipated to arrive in the next year.
Presenters at AMCP 2023 reviewed recent prescription digital therapeutics legislation as well as new proposals anticipated to arrive in the next year.
Presenters at AMCP 2023 reviewed...
03/22/2023
First Report Managed Care
Conference Coverage
Immunotherapy Cost Savings Greater With Atezolizumab vs Pembrolizumab for NSCLC
03/21/2023
Investigators compared the budget impact associated with maintaining atezolizumab as a preferred treatment option vs increasing the market share of pembrolizumab.
Investigators compared the budget impact associated with maintaining atezolizumab as a preferred treatment option vs increasing the market share of pembrolizumab.
Investigators compared the...
03/21/2023
First Report Managed Care
Conference Coverage
Costs, HCRU Higher With Valbenazine Than Deutetrabenazine for Tardive Dyskinesia
03/20/2023
"Further investigation on movement disorder diagnoses codes and variations in provider specialty backgrounds may help elucidate factors that may be driving the differences in health care resource use," investigators said.
"Further investigation on movement disorder diagnoses codes and variations in provider specialty backgrounds may help elucidate factors that may be driving the differences in health care resource use," investigators said.
"Further investigation on...
03/20/2023
First Report Managed Care
Conference Coverage
Hepatitis Delta Diagnosis Associated With Significant Uptick in HCRU
03/20/2023
In light of their findings, researchers advised more effective strategies for hepatitis D screening, diagnosis, and treatment to generate cost savings.
In light of their findings, researchers advised more effective strategies for hepatitis D screening, diagnosis, and treatment to generate cost savings.
In light of their findings,...
03/20/2023
First Report Managed Care

Experts gather to discuss the current and future landscape of managed care pharmacy, including legislative and regulatory updates, business insights, and new research into infectious diseases, cancer treatments, and more.

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use